Abstract
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS) affecting more than two million people worldwide. As the exact etiology of MS remains elusive, the diagnosis of MS is made by referring to the McDonald diagnostic criteria, which utilizes MRI as a tool to identify “demyelinated” MS lesions. In particular, hyperintense lesions on T2-weighted images (T2WI) or so-called “T2-lesions” are considered to represent demyelinated MS lesions. T2WI, however, lacks myelin specificity, and moreover, remyelination could not be depicted by the use of such modality. For the accurate diagnosis and treatment decision-making, or for the future development of remyelination therapeutics, imaging tools to visualize myelin-specific signals are mandatory. In this chapter, the current use and the limitation of imaging modalities in MS diagnosis and treatment will be reviewed, with the introduction of new imaging method, namely q-space Myelin Map (qMM), to be used for visualization of demyelination and remyelination in MS.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Barkhof F, Bruck W, De Groot CJ, Bergers E, Hulshof S, Geurts J, Polman CH, van der Valk P (2003) Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol 60(8):1073–1081
Billiet T, Vandenbulcke M, Madler B, Peeters R, Dhollander T, Zhang H, Deprez S, Van den Bergh BR, Sunaert S, Emsell L (2015) Age-related microstructural differences quantified using myelin water imaging and advanced diffusion MRI. Neurobiol Aging 36(6):2107–2121
Cohen Y, Assaf Y (2002) High b-value q-space analyzed diffusion-weighted MRS and MRI in neuronal tissues—a technical review. NMR Biomed 15(7–8):516–542
Confavreux C, Vukusic S (2006) Natural history of multiple sclerosis: a unifying concept. Brain 129(Pt 3):606–616
Edzes HT, Samulski RT (1977) Cross relaxation and spin diffusion in the proton NMR of dehydrated collagen. Nature 265:521–523
Fragoso YD, Alves-Leon SV, Barreira AA, Callegaro D, Ferreira BML, Finkelsztejn A, Gomes S, Goncalves MVM, Machado MIM, Marques VD, Matta APC, Papais-Alvarenga RM, Pereira SLA, Tauil CB (2015) Fingolimod prescribed for the treatment of multiple sclerosis in patients younger than age 18 years. Pediatr Neurol 53:166–168
Fujiyoshi K, Hikishima K, Nakahara J, Tsuji O, Hata J, Konomi T, Nagai T, Shibata S, Kaneko S, Iwanami A, Momoshima S, Takahashi S, Jinzaki M, Suzuki N, Toyama Y, Nakamura M, Okano H (2016) Application of q-space diffusion MRI for the visualization of white matter. J Neurosci 36(9):2796–2808
Hickman SJ, Toosy AT, Jones SJ, Altmann DR, Miszkeil KA, MacManus DG, barker GJ, Plant GT, Thompson AJ, Miller DH (2004) Serial magnetization transfer imaging in acute optic neuritis. Brain 127(3):692–700
Jensen JH, Helpern JA, Ramani A, Lu H, Kaczynski K (2005) Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med 53(6):1432–1440
King MD, Houseman J, Roussel SA, van Bruggen N, Williams SR, Gadian DG (1994) q-space imaging of the brain. Magn Reson Med 32:707–713
MacKay AL, Laule C (2016) Magnetic resonance of myelin water: an in vivo marker for myelin. Brain Plasticity 2:71–91
MacKay A, Whittall K, Adler J, Li D, Paty D, Graeb D (1994) In vivo visualization of myelin water in brain by magnetic resonance. Magn Reson Med 31(6):673–677
Mallik S, Samson RS, Wheeler-kingshott CA, Miller DH (2014) Imaging outcomes for trials of remyelination in multiple sclerosis. J Neurol Neurosurg Psychiatry 85(12):1396–1404
McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van der Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1):121–127
Nakahara J (2017) Remyelination in multiple sclerosis: pathology and treatment strategies. Clinic Exp Neuroimmunol 8(Suppl 1):40–46
Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O’Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria”. Ann Neurol 58(6):840–846
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havdova E, Huchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292–302
Scalfari A, Knappertz V, Cutter G, Goodin DS, Ashton R, Ebers GC (2013) Mortality in patients with multiple sclerosis. Neurology 81(2):184–192
Schumacher GA, Beebe G, Kibler RF, Kurland LT, Kurtzke JF, McDowell F, Nagler B, Sibley WA, Tourtellotte WW, Willmon TL (1965) Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci 122:552–568
Solomon AJ, Bourdette DN, Cross AH, Applebee A, Skidd PM, Howard DB, Spain RI, Cameron MH, Kim E, Mass MK, Yadav V, Whitham RH, Longbrake EE, Naismith RT, Wu GF, Parks BJ, Wingerchuk DM, Rabin BL, Toledano M, Tobin WO, Kantarci OH, Carter JL, Keegan BM, Weinshenker BG (2016) The contemporary spectrum of multiple sclerosis misdiagnosis: a multicenter study. Neurology 87(13):1393–1399
Tanikawa M, Nakahara J, Hata J, Suzuki S, Fujiyoshi K, Fujiwara H, Momoshima S, Jinzaki M, Nakamura M, Okano H, Takahashi S, Suzuki N (2017) q-space myelin map imaging for longitudinal analysis of demyelination and remyelination in multiple sclerosis patients treated with fingolimod: a preliminary study. J Neurol Sci 373:352–357
Thompson AJ, Banwell BL, Barkhof F, Carrol WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintore M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162–173
Wolff SD, Eng J, Balaban RS (1991) Magnetization transfer contrast: method for improving contrast in gradient-recalled-echo images. Radiology 179:133–137
Zivadinov R (2007) Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis? Neurology 68(22 Suppl 3):S72–S82
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Nakahara, J. (2019). Visualization of Myelin for the Diagnosis and Treatment Monitoring of Multiple Sclerosis. In: Sango, K., Yamauchi, J., Ogata, T., Susuki, K. (eds) Myelin. Advances in Experimental Medicine and Biology, vol 1190. Springer, Singapore. https://doi.org/10.1007/978-981-32-9636-7_15
Download citation
DOI: https://doi.org/10.1007/978-981-32-9636-7_15
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-32-9635-0
Online ISBN: 978-981-32-9636-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)